[
  {
    "ts": null,
    "headline": "Full FDA Approval of EPKINLY Combo Therapy Could Be a Game Changer for AbbVie (ABBV)",
    "summary": "AbbVie recently received full FDA approval for EPKINLY (epcoritamab-bysp) in combination with rituximab and lenalidomide for the treatment of adults with relapsed or refractory follicular lymphoma, following robust Phase 3 results showing significant improvement over standard of care. This landmark regulatory milestone addresses an unmet need in a challenging lymphoma type, potentially expanding AbbVie's reach in oncology and advancing treatment standards for patients with limited...",
    "url": "https://finnhub.io/api/news?id=272af478a0028ecc202487ac779e6f81d3dd199ac9839099ced673b8891f5abd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764007791,
      "headline": "Full FDA Approval of EPKINLY Combo Therapy Could Be a Game Changer for AbbVie (ABBV)",
      "id": 137592709,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie recently received full FDA approval for EPKINLY (epcoritamab-bysp) in combination with rituximab and lenalidomide for the treatment of adults with relapsed or refractory follicular lymphoma, following robust Phase 3 results showing significant improvement over standard of care. This landmark regulatory milestone addresses an unmet need in a challenging lymphoma type, potentially expanding AbbVie's reach in oncology and advancing treatment standards for patients with limited...",
      "url": "https://finnhub.io/api/news?id=272af478a0028ecc202487ac779e6f81d3dd199ac9839099ced673b8891f5abd"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie to Present at the Piper Sandler 37th Annual Healthcare Conference",
    "summary": "AbbVie (NYSE: ABBV) will participate in the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025. Management will participate in a fireside chat at 7:30 a.m. Central time.",
    "url": "https://finnhub.io/api/news?id=2e9964524554e9b1389881f5fcd6c964f5e0adc20a1fb69dd72b0aa0a9d05837",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763989200,
      "headline": "AbbVie to Present at the Piper Sandler 37th Annual Healthcare Conference",
      "id": 137589157,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (NYSE: ABBV) will participate in the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025. Management will participate in a fireside chat at 7:30 a.m. Central time.",
      "url": "https://finnhub.io/api/news?id=2e9964524554e9b1389881f5fcd6c964f5e0adc20a1fb69dd72b0aa0a9d05837"
    }
  },
  {
    "ts": null,
    "headline": "Investors bet on newer technology and indications for CGTs",
    "summary": "The industry is showing enthusiasm for novel technologies that improve safety and carry innovation potential including in vivo CAR-Ts.",
    "url": "https://finnhub.io/api/news?id=10fd0f71f66745a541652a1618003b1f5f77408fd8aacf6024fe63d73c970a50",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763988970,
      "headline": "Investors bet on newer technology and indications for CGTs",
      "id": 137589158,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The industry is showing enthusiasm for novel technologies that improve safety and carry innovation potential including in vivo CAR-Ts.",
      "url": "https://finnhub.io/api/news?id=10fd0f71f66745a541652a1618003b1f5f77408fd8aacf6024fe63d73c970a50"
    }
  },
  {
    "ts": null,
    "headline": "5 Dividend Stocks to Hold for the Next 10 Years",
    "summary": "Investors should be able to count on steady dividends from these great stocks.",
    "url": "https://finnhub.io/api/news?id=43e5eae2bea0d347750541bee91b3e6a13da194e2ffcf4bc2a2965664b10bb01",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763987100,
      "headline": "5 Dividend Stocks to Hold for the Next 10 Years",
      "id": 137589159,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Investors should be able to count on steady dividends from these great stocks.",
      "url": "https://finnhub.io/api/news?id=43e5eae2bea0d347750541bee91b3e6a13da194e2ffcf4bc2a2965664b10bb01"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Insiders Sell US$41m Of Stock, Possibly Signalling Caution",
    "summary": "In the last year, many AbbVie Inc. ( NYSE:ABBV ) insiders sold a substantial stake in the company which may have...",
    "url": "https://finnhub.io/api/news?id=e316323e497cfd86d6b753dc625bde544c08d4b4b059a3c295f36872fa3f9e39",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763982042,
      "headline": "AbbVie Insiders Sell US$41m Of Stock, Possibly Signalling Caution",
      "id": 137589160,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "In the last year, many AbbVie Inc. ( NYSE:ABBV ) insiders sold a substantial stake in the company which may have...",
      "url": "https://finnhub.io/api/news?id=e316323e497cfd86d6b753dc625bde544c08d4b4b059a3c295f36872fa3f9e39"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog JPMorgan, Netflix, AbbVie and Ohio Valley Banc",
    "summary": "JPM shows solid operational strength as analysts highlight its NII outlook, fee pressures and expense trajectory through 2027.",
    "url": "https://finnhub.io/api/news?id=e34f1b434924c7fcd0527ed26a9d6bb8bc02d3fab61755cb33a0dcb3b7db1314",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763978940,
      "headline": "The Zacks Analyst Blog JPMorgan, Netflix, AbbVie and Ohio Valley Banc",
      "id": 137589142,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "JPM shows solid operational strength as analysts highlight its NII outlook, fee pressures and expense trajectory through 2027.",
      "url": "https://finnhub.io/api/news?id=e34f1b434924c7fcd0527ed26a9d6bb8bc02d3fab61755cb33a0dcb3b7db1314"
    }
  }
]